* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Haemochromatosis PCR Testing
Vectors in gene therapy wikipedia , lookup
Tay–Sachs disease wikipedia , lookup
Epigenetics of diabetes Type 2 wikipedia , lookup
No-SCAR (Scarless Cas9 Assisted Recombineering) Genome Editing wikipedia , lookup
BRCA mutation wikipedia , lookup
Genetic engineering wikipedia , lookup
Genome evolution wikipedia , lookup
Gene desert wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Public health genomics wikipedia , lookup
Copy-number variation wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Cell-free fetal DNA wikipedia , lookup
Gene nomenclature wikipedia , lookup
Population genetics wikipedia , lookup
Gene expression programming wikipedia , lookup
Genome (book) wikipedia , lookup
Oncogenomics wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Gene therapy wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Saethre–Chotzen syndrome wikipedia , lookup
Designer baby wikipedia , lookup
Neuronal ceroid lipofuscinosis wikipedia , lookup
Frameshift mutation wikipedia , lookup
CS7.020/Edition: 4 Haemochromatosis PCR Testing Haemochromatosis is an autosomal recessive disorder of iron metabolism. Most cases of haemochromatosis are caused by the C282Y mutation. Approximately 1 in 200 persons of Northern European descent carry 2 copies of this gene and are at risk of developing the complications associated with this condition. Approximately 1 in 8 persons of Northern European descent carry a single copy of the gene. They are unlikely to have any manifestations of haemochromatosis, but may pass the gene copy to their children. Only a proportion of persons who are homozygous (carry 2 copies of the gene) for C282Y develop clinical disease. For those who do, if identified early enough, there is excellent treatment, simply by regular removal of blood which is the main site of iron storage in the body. There are 2 other mutations that have been identified in the haemochromatosis gene, know as the H63D and S65C mutations respectively. They appear to be less important than the C282Y mutation in causing clinical haemochromatosis, but some persons who carry 2 copies of the H63D mutation have been reported to develop clinical signs of haemochromatosis. ACT Pathology performs genetic testing for haemochromatosis. The C282Y and H63D mutations are tested for on a weekly basis, using a technique called PCR. The S65C mutation has no known association with hereditary haemochromatosis and is not reported. Required specimen is 4-10mL of blood collected into an EDTA tube. For further information please contact: Dr Peter Hickman Director of Chemical Pathology 6244 2840 Senior Scientist Molecular Pathology 62443485 Authorised by Director of Chemical Pathology Last Updated: 28/11/2011